Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults

A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis

NCT05061693 ·Status: COMPLETED ·Phase: PHASE2

A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis

NCT06527404 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

MSB11022 in Moderate to Severe Chronic Plaque Psoriasis

NCT02660580 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis

NCT05153148 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis

NCT05640245 ·Status: COMPLETED ·Phase: PHASE2

Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis

NCT04999839 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)

NCT06516952 ·Status: RECRUITING ·Phase: PHASE3

Rimegepant in Moderate Plaque-type Psoriasis

NCT04629950 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)

NCT06687980 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

NCT06641089 ·Status: RECRUITING ·Phase: PHASE3

Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin

NCT05038982 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

NCT06516965 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis

NCT03718299 ·Status: COMPLETED ·Phase: PHASE4

A Worldwide Survey on the Understanding of Psoriatic Disease Among Patients With Psoriasis and Psoriatic Arthritis

NCT04614831 ·Status: COMPLETED

A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)

NCT06687967 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study In Adults With Moderate To Severe Dermatomyositis

NCT03181893 ·Status: COMPLETED ·Phase: PHASE2

Safety Study of the Monoclonal Antibody Teplizumab (MGA031) in Subjects With Moderate or More Severe Psoriasis

NCT00954915 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis

NCT02931838 ·Status: COMPLETED ·Phase: PHASE2

A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis

NCT03418493 ·Status: COMPLETED ·Phase: PHASE1

Study of Psoriatic Arthritis

NCT00001420 ·Status: COMPLETED

Upadacitinib for Prurigo Nodularis

NCT06773403 ·Status: TERMINATED ·Phase: PHASE4

A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis

NCT00540618 ·Status: COMPLETED ·Phase: PHASE2

Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)

NCT04202679 ·Status: COMPLETED ·Phase: PHASE3

Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis

NCT00442650 ·Status: COMPLETED ·Phase: PHASE3

A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment

NCT02207244 ·Status: COMPLETED ·Phase: PHASE3